News Preview
J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show
Johnson & Johnson CEO Joaquin Duato discusses the company's focus on cancer and dementia research, and the potential of artificial intelligence in drug discovery.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.